Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease
high levels of potassium in your blood (hyperkalemia)
Finding your optimal concentration The best copper peptide concentration for your skin depends on multiple factors: current skin condition, sensitivity level, experience with active ingredients, specific goals, and how your skin responds to initial trials
Once applied, these microneedles dissolve naturally , releasing GLP-1 in a steady, controlled manner over time without the spikes or dips often seen with injections
Metabolic bone disease and parenteral nutrition
doi: 10.1016/j.metabol.2010.09.010 57 SimpsonSHMajumdarSRTsuyukiRTEurichDTJohnsonJA